Clinical Trial Update: A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of enteric-coated aspirin in patients at moderate risk of cardiovascular disease has completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• Enteric-coated Acetylsalicylic Acid (acetylsalicylic acid)

Snippet

Sponsor: Bayer | Conditions: Moderate Risk of CVD | Phase 3 | Status: COMPLETED | Results posted: 2018-01-08